This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

MKC1106-PP

Colby Pharmaceutical Company

Drug Names(s): MKC1106-PP

Description: MKC1106-PP is a multi-component active immunotherapy. It is a DNA vector with two synthetic peptides and targets tumour-related antigens PRAME (preferential antigen of melanoma) and PSMA (prostate specific membrane antigen), to induce a cell-mediated immune response.

Partners: MannKind Corporation


MKC1106-PP News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug